Global Antihypertensive Drugs Market 2022-2026

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	120 Pages	TechNavio	September, 2022	INF17419598

Best Price Guarantee
Price	from $2,500
Length	120 Pages
Publisher	TechNavio
Published Date	September, 2022
SKU	INF17419598

Global Antihypertensive Drugs Market 2022-2026

Technavio has been monitoring the antihypertensive drugs market and it is poised to grow by $5.87 bn during 2022-2026, accelerating at a CAGR of 3.1% during the forecast period. Our report on the antihypertensive drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of a wide range of drugs, the rising population with risk factors for hypertension, and increased funds for research on hypertension.

The antihypertensive drugs market analysis includes type segment and geographic landscape.

Technavio's antihypertensive drugs market is segmented as below:

By Type

Systemic hypertension
Pulmonary hypertension

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of modified release formulations as one of the prime reasons driving the antihypertensive drugs market growth during the next few years. Also, the development of novel molecules and a strong incidence of coronary heart disease (CHD) will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the antihypertensive drugs market covers the following areas:

Antihypertensive drugs market sizing
Antihypertensive drugs market forecast
Antihypertensive drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antihypertensive drugs market vendors that include Abbott Laboratories, AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Co Inc, Bayer AG, Cipla Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd, GlaxoSmithKline Plc, Hetero Healthcare Ltd., Johnson and Johnson, Lupin Ltd, Merck and Co. Inc., Norden Pharma DAC, Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc., and Zydus Lifesciences Ltd. Also, the antihypertensive drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Type
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2021
- Market outlook: Forecast for 2021-2026
  - Table Chart on Global - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Global - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2021-2026 (%)
  - Table Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2021 and 2026
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2021 and 2026
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2021 and 2026
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2021 and 2026
- Market condition
  - Table Chart on Market condition - Five forces 2021 and 2026
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2021-2026 (%)
  - Table Data Table on Type - Market share 2021-2026 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- Systemic hypertension - Market size and forecast 2021- 2026
  - Table Chart on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Systemic hypertension - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Systemic hypertension - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Systemic hypertension - Year-over-year growth 2021-2026 (%)
- Pulmonary hypertension - Market size and forecast 2021- 2026
  - Table Chart on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Pulmonary hypertension - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Pulmonary hypertension - Year-over-year growth 2021-2026 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2021-2026 (%)
  - Table Data Table on Market share by geography 2021-2026 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2021-2026
  - Table Chart on North America - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on North America - Market size and forecast 2021-2026 ($ million)
  - Table Chart on North America - Year-over-year growth 2021-2026 (%)
  - Table Data Table on North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026
  - Table Chart on Europe - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Europe - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026
  - Table Chart on Asia - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Asia - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Asia - Year-over-year growth 2021-2026 (%)
- Rest of World (ROW) - Market size and forecast 2021- 2026
  - Table Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- US - Market size and forecast 2021-2026
  - Table Chart on US - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on US - Market size and forecast 2021-2026 ($ million)
  - Table Chart on US - Year-over-year growth 2021-2026 (%)
  - Table Data Table on US - Year-over-year growth 2021-2026 (%)
- Germany - Market size and forecast 2021-2026
  - Table Chart on Germany - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Germany - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Germany - Year-over-year growth 2021-2026 (%)
- UK - Market size and forecast 2021-2026
  - Table Chart on UK - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on UK - Market size and forecast 2021-2026 ($ million)
  - Table Chart on UK - Year-over-year growth 2021-2026 (%)
  - Table Data Table on UK - Year-over-year growth 2021-2026 (%)
- China - Market size and forecast 2021-2026
  - Table Chart on China - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on China - Market size and forecast 2021-2026 ($ million)
  - Table Chart on China - Year-over-year growth 2021-2026 (%)
  - Table Data Table on China - Year-over-year growth 2021-2026 (%)
- Japan - Market size and forecast 2021-2026
  - Table Chart on Japan - Market size and forecast 2021-2026 ($ million)
  - Table Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  - Table Chart on Japan - Year-over-year growth 2021-2026 (%)
  - Table Data Table on Japan - Year-over-year growth 2021-2026 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Availability of wide range of drugs
  - Rising population with risk factors for hypertension
  - Increased funds for research on hypertension
- Market challenges
  - Advent of wearable defibrillators
  - Drug failures in late-stage clinical trials
  - Adverse effects of available drugs
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2021 and 2026
- Market trends
  - Development of modified release formulations
  - Development of novel molecules
  - Strong incidence of coronary heart disease (CHD)
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AstraZeneca Plc
  - Table AstraZeneca Plc - Overview
  - Table AstraZeneca Plc - Product / Service
  - Table AstraZeneca Plc - Key news
  - Table AstraZeneca Plc - Key offerings
- Bayer AG
  - Table Bayer AG - Overview
  - Table Bayer AG - Business segments
  - Table Bayer AG - Key offerings
  - Table Bayer AG - Segment focus
- Dr Reddys Laboratories Ltd
  - Table Dr Reddys Laboratories Ltd - Overview
  - Table Dr Reddys Laboratories Ltd - Business segments
  - Table Dr Reddys Laboratories Ltd - Key offerings
  - Table Dr Reddys Laboratories Ltd - Segment focus
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key news
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- Johnson and Johnson
  - Table Johnson and Johnson - Overview
  - Table Johnson and Johnson - Business segments
  - Table Johnson and Johnson - Key news
  - Table Johnson and Johnson - Key offerings
  - Table Johnson and Johnson - Segment focus
- Lupin Ltd
  - Table Lupin Ltd - Overview
  - Table Lupin Ltd - Product / Service
  - Table Lupin Ltd - Key news
  - Table Lupin Ltd - Key offerings
- Merck and Co. Inc.
  - Table Merck and Co. Inc. - Overview
  - Table Merck and Co. Inc. - Business segments
  - Table Merck and Co. Inc. - Key news
  - Table Merck and Co. Inc. - Key offerings
  - Table Merck and Co. Inc. - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Sanofi SA
  - Table Sanofi SA - Overview
  - Table Sanofi SA - Business segments
  - Table Sanofi SA - Key news
  - Table Sanofi SA - Key offerings
  - Table Sanofi SA - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations